Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	5,038	3,161	1,839	3,422	3,418	362.82
Short-Term Investments	5,279	-	-	4,929	2,691	-
Trading Asset Securities	-	4,161	4,591	-	-	2,091
Cash & Short-Term Investments	10,318	7,323	6,429	8,351	6,109	2,454
Cash Growth	52.75%	13.90%	-23.01%	36.70%	148.94%	-
Accounts Receivable	5,773	4,504	4,904	2,741	3,262	2,546
Other Receivables	-	95.15	1.96	12.15	73.23	23.47
Receivables	5,773	4,599	4,906	2,753	3,335	2,570
Inventory	1,858	3,404	2,113	1,294	582.3	350.63
Prepaid Expenses	-	2.14	31.67	19.43	25.04	17.68
Restricted Cash	-	-	-	-	-	40.02
Other Current Assets	3,892	2,039	1,335	814.18	881.44	725.69
Total Current Assets	21,841	17,367	14,816	13,232	10,933	6,158
Property, Plant & Equipment	10,295	9,981	8,210	6,039	4,759	3,737
Long-Term Investments	169.28	169.28	125.53	61.6	36.96	-
Other Intangible Assets	30.94	38.71	62.43	90.89	68.99	64.18
Long-Term Accounts Receivable	-	31.12	31.08	31.08	31.12	31.28
Long-Term Deferred Tax Assets	251.03	179.47	413.95	249.08	159.38	138.7
Other Long-Term Assets	206.3	253.87	249.73	370.15	127.81	136.9
Total Assets	32,843	28,076	23,981	20,145	16,189	10,338
Accounts Payable	776.03	1,101	1,007	719.41	648.41	769.25
Accrued Expenses	24.61	252.29	308.02	249.82	245.63	267.01
Short-Term Debt	-	429.53	817.96	87.46	274.93	213.84
Current Portion of Long-Term Debt	690.66	189.74	390.71	201.3	11.5	577.92
Current Portion of Leases	13.87	15.06	16.85	3.22	21.22	22.44
Current Income Taxes Payable	268.47	230.27	64.11	58.83	193.89	256.99
Current Unearned Revenue	-	-	-	3.85	-	8.23
Other Current Liabilities	2,867	1,045	781.21	314.81	866.29	734.14
Total Current Liabilities	4,641	3,262	3,386	1,639	2,262	2,850
Long-Term Debt	373.56	470.28	1,117	961.88	245.8	174.64
Long-Term Leases	22.08	28.56	43.06	7.64	24.39	34.88
Long-Term Unearned Revenue	8.17	9.35	11.69	14.18	16.64	19.02
Pension & Post-Retirement Benefits	-	43.87	39.78	33.6	31.99	47.97
Other Long-Term Liabilities	273.04	162.81	137.21	81.89	57.99	197.33
Total Liabilities	5,318	3,977	4,735	2,738	2,639	3,324
Common Stock	1,123	1,118	1,118	1,141	87.76	84.85
Additional Paid-In Capital	-	1,252	1,252	2,719	2,700	228.1
Retained Earnings	-	21,392	16,879	13,570	10,726	6,658
Comprehensive Income & Other	26,402	336.79	-2.72	-23.05	35.82	44.15
Shareholders' Equity	27,525	24,099	19,247	17,407	13,550	7,015
Total Liabilities & Equity	32,843	28,076	23,981	20,145	16,189	10,338
Total Debt	1,100	1,133	2,385	1,262	577.84	1,024
Net Cash (Debt)	9,217	6,190	4,044	7,090	5,531	1,430
Net Cash Growth	71.00%	53.05%	-42.96%	28.17%	286.71%	-
Net Cash Per Share	16.44	11.02	7.13	12.43	9.70	2.62
Filing Date Shares Outstanding	561.26	561.61	559.08	570.49	570.46	546.78
Total Common Shares Outstanding	561.26	559.08	559.08	570.49	570.46	546.78
Working Capital	17,200	14,105	11,429	11,593	8,671	3,308
Book Value Per Share	49.04	43.10	34.43	30.51	23.75	12.83
Tangible Book Value	27,495	24,060	19,184	17,316	13,481	6,950
Tangible Book Value Per Share	48.99	43.04	34.31	30.35	23.63	12.71
Land	-	836.13	836.13	836.13	836.13	836.13
Buildings	-	3,239	2,012	1,579	1,304	1,304
Machinery	-	8,595	6,761	6,137	4,632	4,439
Construction In Progress	-	2,969	3,447	1,641	1,538	186.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.